118 related articles for article (PubMed ID: 21327899)
21. Stage I testicular cancer management and necessity for surgical expertise.
Sheinfeld J; Motzer RJ
J Clin Oncol; 2008 Jun; 26(18):2934-6. PubMed ID: 18458042
[No Abstract] [Full Text] [Related]
22. Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: a pediatric intergroup study--Pediatric Oncology Group 9049 and Children's Cancer Group 8882.
Cushing B; Giller R; Cullen JW; Marina NM; Lauer SJ; Olson TA; Rogers PC; Colombani P; Rescorla F; Billmire DF; Vinocur CD; Hawkins EP; Davis MM; Perlman EJ; London WB; Castleberry RP; ;
J Clin Oncol; 2004 Jul; 22(13):2691-700. PubMed ID: 15226336
[TBL] [Abstract][Full Text] [Related]
23. [Urologic treatment of testicular germ cell cancer].
Fernández Gómez JM; Escaf Barmadah S; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; García Rodríguez J; Rodríguez Faba O; Jalón Monzón A; Rodríguez Martínez JJ
Arch Esp Urol; 2002 Oct; 55(8):927-36. PubMed ID: 12455283
[TBL] [Abstract][Full Text] [Related]
24. Salvage chemotherapy with high-dose carboplatin and etoposide with peripheral blood stem cell transplant in patients with relapsed pure seminoma.
Agarwala AK; Perkins SM; Abonour R; Brames MJ; Einhorn LH
Am J Clin Oncol; 2011 Jun; 34(3):286-8. PubMed ID: 20523207
[TBL] [Abstract][Full Text] [Related]
25. [Modified retroperitoneal lymphadenectomy in non-seminomatous stage I, IIa and IIb testicular tumors].
Sparwasser C; Treiber U; Beckert R; Pust RA
Urologe A; 1995 Nov; 34(6):444-8. PubMed ID: 8848854
[TBL] [Abstract][Full Text] [Related]
26. Clinical study for management of supportive treatment for high-dose chemotherapy with peripheral blood stem cell transplantation (PBSCT) for intractable testicular tumor.
Shigemura K; Tanaka K; Hara I; Muramaki M; Arakawa S; Fujisawa M
Hinyokika Kiyo; 2006 Jul; 52(7):531-6. PubMed ID: 16910585
[TBL] [Abstract][Full Text] [Related]
27. Long-term efficacy of two cycles of BEP regimen in high-risk stage I nonseminomatous testicular germ cell tumors with embryonal carcinoma and/or vascular invasion.
Chevreau C; Mazerolles C; Soulié M; Gaspard MH; Mourey L; Bujan L; Plante P; Rischmann P; Bachaud JM; Malavaud B
Eur Urol; 2004 Aug; 46(2):209-14; discussion 214-5. PubMed ID: 15245815
[TBL] [Abstract][Full Text] [Related]
28. [Chemotherapy for metastatic germ cell tumours of the testis].
Culine S
Rev Prat; 2007 Feb; 57(4):385-8. PubMed ID: 17455740
[TBL] [Abstract][Full Text] [Related]
29. Long-term results following adjuvant chemotherapy in patients with clinical stage I testicular nonseminomatous malignant germ cell tumors with high risk factors.
Böhlen D; Borner M; Sonntag RW; Fey MF; Studer UE
J Urol; 1999 Apr; 161(4):1148-52. PubMed ID: 10081858
[TBL] [Abstract][Full Text] [Related]
30. [Advanced germinal tumors of the testicle: clinical experience with cisplatin, bleomycin and vinblastine (PVB) or etoposide (BEP)].
Alonso Curbera G; González-Manzano R; Aramendía Beitia JM; Martínez Monge R; Agüera Fernández L; Rebollo Liceaga J
Rev Med Univ Navarra; 1993; 38(1):13-8. PubMed ID: 8711305
[TBL] [Abstract][Full Text] [Related]
31. Alternatives to standard BEP x 3 in good-prognosis germ cell tumors--you bet your life.
Nichols C; Kollmannsberger C
J Natl Cancer Inst; 2010 Aug; 102(16):1214-5. PubMed ID: 20631340
[No Abstract] [Full Text] [Related]
32. Metastatic seminoma treated with either single agent carboplatin or cisplatin-based combination chemotherapy: a pooled analysis of two randomised trials.
Bokemeyer C; Kollmannsberger C; Stenning S; Hartmann JT; Horwich A; Clemm C; Gerl A; Meisner C; Rückerl CP; Schmoll HJ; Kanz L; Oliver T
Br J Cancer; 2004 Aug; 91(4):683-7. PubMed ID: 15266338
[TBL] [Abstract][Full Text] [Related]
33. Report of the long-term efficacy of two cycles of adjuvant bleomycin/etoposide/cisplatin in patients with stage I testicular nonseminomatous germ-cell tumors (NSGCT): a risk adapted protocol of the Hellenic Cooperative Oncology Group.
Bamias A; Aravantinos G; Kastriotis I; Alivizatos G; Anastasiou I; Christodoulou C; Gyftaki R; Kalofonos HP; Dimopoulos MA
Urol Oncol; 2011; 29(2):189-93. PubMed ID: 19362863
[TBL] [Abstract][Full Text] [Related]
34. [Stage II non-seminoma cancer of the testis: combined treatment with surgery and chemotherapy].
Orlandi L; Van Cauwelaert R; Orlandi F; Vargas R; San Martín S; Arraztoa J
Actas Urol Esp; 1989; 13(1):53-5. PubMed ID: 2469300
[TBL] [Abstract][Full Text] [Related]
35. [A case of synchronous cervical lymph node metastases from testicular and thyroid cancers showing mixed response to chemotherapy].
Matsumoto H; Nakane H; Aoki A; Naito K; Imate Y; Ohkami K; Isoyama R
Hinyokika Kiyo; 2000 Jul; 46(7):505-8. PubMed ID: 10965461
[TBL] [Abstract][Full Text] [Related]
36. [High dose chemotherapy with autologous stem cell support in the treatment of germ cell tumors: experience of the centre Léon-Bérard between 1982 and 1996].
Fléchon A; Biron P; Philip I; Blay JY; Droz JP
Bull Cancer; 1999 Apr; 86(4):391-9. PubMed ID: 10341344
[TBL] [Abstract][Full Text] [Related]
37. [New testis tumor study AH 09/03/XX--darbepoetin activated].
Rexer H
Urologe A; 2004 May; 43(5):586. PubMed ID: 15083275
[No Abstract] [Full Text] [Related]
38. High-dose chemotherapy in nonseminomatous germ cell cancer.
Kollmannsberger C; Beyer J; Bokemeyer C
BJU Int; 2009 Nov; 104(9 Pt B):1398-403. PubMed ID: 19840020
[No Abstract] [Full Text] [Related]
39. Reduced dose PVB treatment of stage IIC-IV testicular seminoma.
Berkmen F
Eur J Surg Oncol; 1993 Feb; 19(1):24-6. PubMed ID: 7679655
[TBL] [Abstract][Full Text] [Related]
40. Is bleomycin necessary in adjuvant chemotherapy of clinical stage I non-seminomatous testicular cancer?
Mezvrishvili Z; Managadze L
Georgian Med News; 2006 May; (134):25-8. PubMed ID: 16783058
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
